First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Resultsbenzinga_article·Aug 13 at 08:07 AMTRAX+0.02%
First Tracks Biotherapeutics | 8-K: FY2026 Q2 Revenue: USD 0Earnings Watch·Aug 12 at 03:57 PMTRAX+0.02%
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business UpdateUnusual Whales·Aug 12 at 03:29 PMTRAX+0.02%
Biotech Stocks At 52-Week Highs- CORT +30%, NEOG +22% & BAX +7% With Quarterly Results, TRAX, XNCRrttnews·Jul 31 at 06:00 AMBAX-1.18%NEOG-2.02%
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquiredrttnews·Jul 27 at 10:34 PMFBRX-0.04%TVGNW0.00%
First Tracks Biotherapeutics: Buy Rating Reaffirmed with Unchanged $44 Price Target on ANB033 CD122-Targeting Upside and Acquisition PotentialTip Ranks·Jul 27 at 11:55 AMTRAX+0.02%FBRX-0.04%
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga_article·Jul 27 at 07:05 AMMPLT+1.47%MTNB+0.43%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 07:06 AMSXTC+31.21%HYFT+1.44%
Capital Moves Take Center Stage: From AutoZone's Massive Buyback to Biotech DebutsGlobal Report·Jul 14 at 06:47 AMAZO-0.51%TRAX+0.02%
First Tracks Biotherapeutics shares are trading higher after HC Wainwright & Co. maintained its Buy rating on the stock and raised its price target from $30 to $44.benzinga_article·Jul 10 at 11:34 AMTRAX+0.02%
Biotech Stocks At 52-Week Highs: TRAX, BBIO, MNPR, TXG, MPLTrttnews·Jul 10 at 07:21 AMTRAX+0.02%MPLT+1.47%
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga_article·Jul 9 at 12:05 PMVRAX+1.42%IONS+2.45%
Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and VitiligoTip Ranks·Jul 8 at 08:25 AMTRAX+0.02%
